Impax to Sell Authorized Generic Renvela - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 5:14PM CDT
Impax has started shipping the authorized generic version of Sanofi's Renvela (800 mg) under its settlement agreement with the latter.
Regulatory Update from Impax - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 3:55PM CDT
Impax resubmitted a new drug application (NDA) for Rytary for the symptomatic treatment of Parkinson's disease (PD).
Mylan to Settle with Endo on Frova - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 14, 10:40AM CDT
A federal district court granted Mylan's request to forge a settlement with Endo regarding Frova.
3 Humongous Health-Care Stocks This Week
Keith Speights, The Motley Fool - Motley Fool - Sun Apr 13, 9:30AM CDT
Is the biotech bubble bursting? Maybe -- but certainly not for every biotech stock. Three of the biggest of this week experienced gains of at least 17%. One benefited from positive preliminary data from an early-stage clinical trial. Another surged...
ImmunoGen Up on Positive Pipeline Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 4:00PM CDT
ImmunoGen's shares have been up over a couple of trading sessions following positive pipeline results.
Acquisitions, Trial Study Results, Drug Trend Reports, Conference Call Schedules, and Product Launches - Analyst Notes on Mallinckrodt, Amgen, Express Scripts, CR Bard, and Jazz
PR Newswire - Thu Apr 10, 10:36AM CDT
Today, Analysts Review released its analysts' notes regarding Mallinckrodt plc (NYSE: MNK), Amgen Inc. (NASDAQ: AMGN), Express Scripts Inc. (NASDAQ: ESRX), CR Bard Inc. (NYSE: BCR), and Jazz Pharmaceuticals plc (NASDAQ: JAZZ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
3 Stocks Spiking on Unusual Volume
at The Street - Thu Apr 10, 8:28AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
Mallinckrodt plc (MNK) in Focus: Stock Moves 5.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 09, 7:37AM CDT
Mallinckrodt plc as the company saw its shares rise more than 5% on the day.
Questcor Buyout Shocks Short Sellers
Keith Speights, The Motley Fool - Motley Fool - Tue Apr 08, 5:30PM CDT
Activist short seller Andrew Left's Citron Research frequently uses the phrase: "It's never a problem until it's a problem." Monday's news about specialty pharmaceutical firm Mallinckrodt 's acquisition of Questcor Pharmaceuticals put a new...
NYSE stocks posting largest volume increases
AP - Tue Apr 08, 5:29PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
QUESTCOR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
Business Wire - Tue Apr 08, 4:20PM CDT
Rigrodsky & Long, P.A.:
Mallinckrodt to Acquire Questcor - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 08, 4:15PM CDT
Shares of Questcor Pharmaceuticals were up 18.7% after Dublin-based specialty pharmaceutical company Mallinckrodt announced that it has entered into a definitive agreement to acquire the former for $5.6 billion.
Active Stocks Coverage -- Research on Mallinckrodt, American Eagle Outfitters, Blackstone, and Inovio Pharma
PR Newswire - Tue Apr 08, 12:01PM CDT
The trading session on Monday, April 07, 2014 ended on a lower note as the Dow Jones Industrial Average finished at 16,245.87, down 1.02% and the NASDAQ Composite closed at 4,079.75, down 1.16%. The S&P 500 finished the session 1.08% lower at 1,845.04. The losses were broad based as nine out of ten sectors posted losses. Investor-Edge looks at some of the equities which attracted the most attention and traded the most shares during the session. These include Mallinckrodt PLC (NYSE: MNK), American Eagle Outfitters Inc. (NYSE: AEO), Blackstone Group L.P. (NYSE: BX) and Inovio Pharmaceuticals Inc. (NYSE MKT: INO). Free technical research on MNK, AEO, BX and INO can be downloaded upon signing up at:
Jim Cramer: In the Abstract, the Shorts May Be Right
at The Street - Tue Apr 08, 10:19AM CDT
But in the real world they're wrong, as the Questcor buyout demonstrates.
Jim Cramer's Mad Dash: QCOR MNK
at The Street - Tue Apr 08, 9:42AM CDT
Investors don't know what to make of Mallinckrodt's planned acquisition of Questcor, Cramer says.
Company News for April 08, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Tue Apr 08, 9:06AM CDT
Companies in the News are: QCOR,MNK,GAS,MNKD,PBR
Mallinckrodt plc Takes a Big Swing for Growth
Stephen D., Simpson,, The Motley Fool - Motley Fool - Tue Apr 08, 8:30AM CDT
Facing declining market share in its core generic controlled substance (painkillers) market and holding the valuable asset of an Irish tax domicile, Mallinckrodt plc has aggressively put its balance sheet to work. First the company...
Myriad, Tata Motors Among RS Leaders In Correction
at Investor's Business Daily - Tue Apr 08, 7:02AM CDT
The market is in a correction and growth stocks are taking the biggest hit. But just because a company's stock is falling doesn't mean it isn't still a leader. Smart investors should be on the lookout for companies whose Relative Strength lines are...
Jim Cramer's Top Stock Picks: FSLR NFLX AMZN TSLA PCLN
at The Street - Tue Apr 08, 5:00AM CDT
Priceline is Cramer's favorite in the over $500 a share category while First Solar is best of breed and very inexpensive.
Mallinckrodt to Buy Drugmaker Questcor Pharmaceuticals for about $5.6B; Tesla Rated "Outperform" by RW Baird
ACCESSWIRE - Tue Apr 08, 12:00AM CDT
Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) - For an in-depth report on Ariad Pharmaceuticals Inc. follow: www.BullTrends.com/stockquote/ARIA